Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

FinanceClub_UoM 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.90
14.11.20
-
14.11.21
23.24%
27.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
14.11.20 50%
sell
Enzon Pharmaceuticals

Start price
Target price
Perf. (%)
€0.10
14.11.20
-
14.11.21
120.00%
14.01.21

Risky Investment
Nicheplayer
Higher risks for its business
SpringheelJack 
14.11.20 50%
sell
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.15
13.11.20
-
13.11.21
30.20%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
13.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.60
13.11.20
€52.00
1.38%
14.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
13.11.20 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.97
12.11.20
€50.00
12.11.21
21.49%
13.07.21

Top 10 in its market
Small cyclical dependencies
Below average Management
Partizan 
12.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€24.26
09.11.20
-
09.11.21
21.35%
14.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Judge 
09.11.20 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stipica 
09.11.20 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.30
07.11.20
-
07.11.21
15.65%
15.07.21

Probably not worthwhile Investment
Biotechhunter 
07.11.20 50%
sell
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€5.80
07.11.20
-
07.11.21
-0.34%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
07.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
07.11.20 50%
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€9.36
06.11.20
€14.00
06.11.21
23.50%
21.09.21

Could be worthwhile Investment >10% per year
melinda 
06.11.20 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.26
04.11.20
€3.20
04.11.21
-43.45%
10.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
04.11.20 50%
sell
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.40
04.11.20
-
-9.38%
07.11.20

Could be very worthwhile Investment >20% year
Biotechhunter 
04.11.20 50%
sell
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
shadow 
04.11.20 50%
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.46
03.11.20
€3.50
04.11.21
-4.88%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
03.11.20 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
NightTrain 
03.11.20 50%
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€9.55
02.11.20
€11.00
04.11.21
4.19%
16.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
02.11.20 50%